Optimized automated apolipoprotein A-I assays as markers for coronary artery disease

Archives of Pathology and Laboratory Medicine

Volumn 121, Issue 7, 1997, Pages 678-684

  Levinson, Stanley S ^a   Hobbs, Gregory A ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; BIOLOGICAL MARKER; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; POLYSORBATE 20; REAGENT; TRIACYLGLYCEROL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ASSAY; AUTOMATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC ACCURACY; HUMAN; MAJOR CLINICAL STUDY; MALE; RECEIVER OPERATING CHARACTERISTIC;

ADULT; AGED; APOLIPOPROTEIN A-I; BIOLOGICAL MARKERS; CHOLESTEROL, HDL; CORONARY ANGIOGRAPHY; CORONARY DISEASE; HUMANS; MALE; MIDDLE AGED; POLYSORBATES;

EID: 0030802303     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Marcovia SM, Albers JJ, Henderson LO, Hannon WH. International federation of clinical chemistry standardization project for measurement of apolipoproteins A-I and B: comparability of apolipoprotein A-I values by use of international reference material. Clin Chem. 1993;39:773-781.
2. Maciejko JJ, Homes DR, Kottke BA, Zinsmeister AB, Dinh DM, Mao SJT. Apolipoprotein AI as a marker of angiographically assessed coronary artery disease. N Engl J Med. 1983;309:385-389.
3. Kottke BA, Zinsmeister AR, Holmes DR Jr, et al. Apolipoproteins and coronary artery disease. Mayo Clin Proc. 1986;61:313-320.
4. Kweiterovich PO Jr, Coresh J, Smith HH, Bachorik PS, Derby CA, Pearson TA. Comparison of the plasma levels of apolipoproteins B and A1, and other risk factors in men and women with premature coronary artery disease. Am J Cardiol. 1992;69:1015-1021.
5. Hamsten A, Walldius G, Szamoski A, Dahlen G, Faire U. Relationship of angiographically defined coronary artery disease to serum lipoproteins and apoproteins in young survivors of myocardial infarction. Circulation. 1986;73:1097-1110.
6. Johansson S, Bondjers G, Fager G, et al. Serum lipids and apolipoprotein levels in women with acute myocardial infarction. Artherosclerosis. 1988;8:742-749.
7. Stampfer MJ, Sacks FM, Salvini WC, Willett WC, Hennekens CH. A prospective study of cholesterol, apolipoproteins, and risk of myocardial infarction. N Engl J Med. 1991;325:373-381.
8. Levinson SS, Wagner S. The relative usefulness of automated apolipoprotein A-I and high density lipoprotein cholesterol assays as markers for coronary artery disease. Am J Clin Pathol. 1994;101:104-108.
9. Mao SJT, Miller J, Gotto AM Jr, Sparrow JT. The antigenic structure of apolipoprotein AI in high density lipoproteins. J Biol Chem. 1980;255:3448-53.
10. Maciejko JJ, Mao STJ. Radioimmunoassay of apolipoprotein A-I: application of a non-ionic detergent (Tween-20) and solid-phase staphylococcus. Clin Chem. 1982;28:199-204.
11. Rosseneu M, Vinaimont N, Musliner TA, et al. Immunonephelometry of apolipoprotein A-II in plasma Clin Chem. 1984;30:234-237.
12. Rothwell TC, Kamanna VS, Jin F-Y, Koren E, Foley T, Kashyap ML. Characterization of a monoclonal antibody (HB-22) and development of an ELISA for human apolipoprotein A-I. Clin Chem. 1995;41:1150-1158.
13. Levinson SS, Wagner S. Assay of apolipoprotein B containing lipoproteins for routine use. Arch Pathol Lab Med. 1992;116:1350-1354.
14. 2+/dextran sulfate in its enzymatic measurement. Clin Chem. 1978;24:931-933.
15. Warnick GR, Nguyen T, Albers JJ. Comparison of improved precipitation methods for quantitation of high-density lipoprotein cholesterol. Clin Chem. 1985;31:217-222.
16. Harris N, Galpchian V, Rifai N. Three routine methods for measuring high-density lipoprotein cholesterol compared with the reference method. Clin Chem. 1996;42:738-743.
17. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol without the use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
18. Levinson SS, Wagner S. Immunonephelometric/turbidimetric apolipoprotein B assays for routine clinical laboratory use in cardiovascular disease. Clin Chim Acta. 1993;223:31-42.
19. Maciejko JJ, Levinson SS, Markyvech L, Smith M. Evaluation of a new method for assaying APO A-I and APO B lipoproteins by rate nephelometry. Clin Chem. 1987;11:2065-2069.
20. Brustolin D, Maierna M, Aguzzi F, et al. Immunoturbidimetric method for routine determinations of apolipoproteins A-I and B. Clin Chem. 1991;37:742-747.
21. Glueck CJ, MaCray C, Speirs J. Measurement of serum apo AI and apo B: comparison of immunoturbidimetric and rate nephelometric techniques. Clin Chim Acta. 1991;197:123-132.
22. Levinson SS. Problems with measurement of apolipoproteins AI and AII. Ann Clin Lab Sci. 1990;20:307-317.
23. Gordon T, Castelli WP, Hjortland MC, et al. High density lipoprotein as a protective factor against coronary heart disease. Am J Med. 1977;62:707-714.
24. Grover SA, Coupal L, Xiao-Ping H. Identifying adults at increased risk of coronary artery disease. J Am Med Assoc. 1995;274:801-806.
25. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AC. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. J Am Med Assoc. 1995;274:1049-1057.
26. Shipchandler MT, Moore EG. Rapid, fully automated measurement of plasma homocyst(e)ine with the Abbott IMx® Analyzer. Clin Chem. 1995;41:991-994.
27. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, Macfarlen PW, for the West of Scotland Prevention Study Group. Prevention of coronary heart disease with provastation in men with hypercholesterolemia. N Engl J Med. 1995;333:1301-1307.